Controversial FDA official leaving drug center post in latest departure at agency

Dr. Tracy Beth Høeg, leader of the Food and Drug Administration division responsible for regulating prescription and over-the-counter drugs, is leaving her post, a senior FDA official confirmed.

Exclusive-FDA drug center head expected to leave after commissioner's exit, sources say

By Yasmeen Abutaleb and Michael Erman WASHINGTON, May 15 (Reuters) - The acting head of the U.S. Food and Drug Administration ...
The Daily Signal

Acting FDA Commissioner Promises Transparency, Action on Abortion Pill

Kyle Diamantas, FDA deputy commissioner for food, is serving as acting FDA commissioner in the wake of Dr. Marty Makary’s ...
MedPage Today

Here's What Stakeholders Want From the Next FDA Commissioner

Stakeholders across the board are calling for a return to regular order at the FDA following the resignation of Commissioner ...

FDA revamps leadership, replaces top drug and vaccine regulators

Several key allies of former Food and Drug Administration commissioner Marty Makary are departing their posts, according to ...
Medical Device Network

Biopharma industry endorses Pazdur for FDA commissioner role

Hundreds of biopharma leaders say Dr Richard Pazdur has the necessary qualities to lead the FDA amid a crisis of confidence.

New FDA leader rushes to reassure anti-abortion leaders. They still have questions

Kyle Diamantas, who was elevated to FDA acting commissioner earlier this week, is telling anti-abortion groups he asked to be ...

FDA exit could threaten abortion access nationwide

Mifepristone is one of two drugs used in medication abortions, the most common method of ending a pregnancy. It has become a ...